4//SEC Filing
Morag Eyal 4
Accession 0001493152-20-013462
CIK 0000883975other
Filed
Jul 15, 8:00 PM ET
Accepted
Jul 16, 5:05 PM ET
Size
5.9 KB
Accession
0001493152-20-013462
Insider Transaction Report
Form 4
Morag Eyal
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2020-07-14+25,000→ 25,000 totalExercise: $6.16Exp: 2030-07-14→ Common Stock, par value $0.01 per share (25,000 underlying)
Footnotes (1)
- [F1]The options vest as follows and in accordance with the terms of the Issuer's 2017 Equity Incentive Plan (the "Plan"): (a) on December 15, 2020, the option shall vest and shall become exercisable with respect to 25% of the common stock; and (b) on a quarterly basis over the next 30 months, the option shall equally vest and become exercisable with respect to the remaining 75% of the common stock, subject to acceleration pursuant to the terms of the Plan and with respect to certain business transactions.
Documents
Issuer
Microbot Medical Inc.
CIK 0000883975
Entity typeother
Related Parties
1- filerCIK 0001805787
Filing Metadata
- Form type
- 4
- Filed
- Jul 15, 8:00 PM ET
- Accepted
- Jul 16, 5:05 PM ET
- Size
- 5.9 KB